Package 60505-6050-4

{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "93afcbae-d69f-36b4-8470-ef4ea151e72b", "openfda": {"nui": ["N0000175604", "N0000175075"], "upc": ["0360505605040"], "unii": ["69G8BD63PP"], "rxcui": ["402243"], "spl_set_id": ["b605b541-4bfd-db3e-9710-11c27f6dee6c"], "pharm_class_epc": ["Proteasome Inhibitor [EPC]"], "pharm_class_moa": ["Proteasome Inhibitors [MoA]"], "manufacturer_name": ["Apotex Corp"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (60505-6050-4)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL", "package_ndc": "60505-6050-4", "marketing_start_date": "20220502"}], "brand_name": "BORTEZOMIB", "product_id": "60505-6050_93afcbae-d69f-36b4-8470-ef4ea151e72b", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Proteasome Inhibitor [EPC]", "Proteasome Inhibitors [MoA]"], "product_ndc": "60505-6050", "generic_name": "bortezomib", "labeler_name": "Apotex Corp", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BORTEZOMIB", "active_ingredients": [{"name": "BORTEZOMIB", "strength": "3.5 mg/1"}], "application_number": "ANDA205533", "marketing_category": "ANDA", "marketing_start_date": "20220502", "listing_expiration_date": "20261231"}